Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Cancer
|
April 15, 1997
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer
E R Broun, C R Nichols, G Gize, et al.
Journal of Hematotherapy
|
June 1, 1999
Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells
R E Pyatt, L L Jenski, R Allen, et al.
Human Gene Therapy
|
October 1, 1993
Infection of human cells with murine amphotropic replication-competent retroviruses
K Cornetta, N Nguyen, R A Morgan, et al.
Bone Marrow Transplantation
|
September 12, 2001
Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation
A K Siston, M A List, C K Daugherty, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells
S Morecki, E Karson, K Cornetta, et al.
Bone Marrow Transplantation
|
September 1, 1995
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors
E R Broun, C R Nichols, R Mandanas, et al.
Gene Therapy
|
June 27, 2008
Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource
B Peters, S Dirscherl, J Dantzer, et al.
Annals of Hematology
|
November 1, 1995
Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice
H E Broxmeyer, S Cooper, N Hague, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 7, 2001
The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells
S E Braun, K Chen, R G Foster, et al.
Cancer Gene Therapy
|
April 29, 2006
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase
K Cornetta, J Croop, E Dropcho, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Cancer
|
April 15, 1997
Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer
E R Broun, C R Nichols, G Gize, et al.
Journal of Hematotherapy
|
June 1, 1999
Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells
R E Pyatt, L L Jenski, R Allen, et al.
Human Gene Therapy
|
October 1, 1993
Infection of human cells with murine amphotropic replication-competent retroviruses
K Cornetta, N Nguyen, R A Morgan, et al.
Bone Marrow Transplantation
|
September 12, 2001
Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation
A K Siston, M A List, C K Daugherty, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1991
Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells
S Morecki, E Karson, K Cornetta, et al.
Bone Marrow Transplantation
|
September 1, 1995
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors
E R Broun, C R Nichols, R Mandanas, et al.
Gene Therapy
|
June 27, 2008
Automated analysis of viral integration sites in gene therapy research using the SeqMap web resource
B Peters, S Dirscherl, J Dantzer, et al.
Annals of Hematology
|
November 1, 1995
Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice
H E Broxmeyer, S Cooper, N Hague, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 7, 2001
The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells
S E Braun, K Chen, R G Foster, et al.
Cancer Gene Therapy
|
April 29, 2006
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase
K Cornetta, J Croop, E Dropcho, et al.
Page
of 10